sharecast

{{ storiesRelated.title }}

Company News
12 Nov
dl bayer ag germany frankfurt dax pharmaceuticals biotechnology logo 20230228
Bayer cuts earnings outlook, shares tumble

Bayer shares tumbled on Tuesday as it cut its full-year earnings guidance.

12 Nov
dl franchise brands aim multibrand multi brand franchisor group master logo
Franchise Brands shares drop on uncertain outlook

Shares in AIM-listed Franchise Brands dropped sharply on Tuesday after the franchisor said that full-year profits are likely to come in at the lower end of market forecasts.

12 Nov
dl cake box aim cakebox egg free eggfree baking cakes confections franchise logo
Cake Box upbeat after strong first half

Cake Box reported a strong first-half performance on Tuesday, with revenue increasing 4. 3% to £18. 7m, supported by positive momentum in franchise store sales and expanding online demand.

12 Nov
dl bae systems typhoon
BAE holds guidance, sees growth from global tensions

UK arms maker BAE Systems held annual guidance adding that its order book reflected demand from governments for weaponry amid increasing global tensions.

12 Nov
dl renewi waste to products recycling reuse esg green sustainable waste trash rubbish logo
Renewi reports 'tangible progress' in first half

Renewi reported a solid first-half performance on Tuesday, with revenue from continuing operations up 4% to €874. 5m, driven by strong pricing in its commercial waste division and significant growth in specialities.

12 Nov
dl 4imprint group plc ftse 250 consumer discretionary media agencies logo
4Imprint confident after US election cycle 'distraction'

4imprint Group reported a robust performance for the 10 months through October in an update on Tuesday, achieving revenue growth and maintaining profitability in a challenging North American market.

12 Nov
dl vodafone group plc ftse 100 telecommunications service providers telecommunications services logo
Vodafone reiterates guidance after first-half revenue growth

Vodafone Group reported a 1. 6% rise in total revenue to €18. 3bn for the first half of its financial year on Tuesday, with service revenue growing 1. 7% to €15. 1bn.

12 Nov
dl oxford instruments scientific equipment laboratory research and development logo ftse 250
Oxford Instruments confident despite some market softness

Oxford Instruments reported first-half revenue growth and strategic progress on Tuesday, recording a 10. 4% increase in revenue at constant currency to £225. 8m, supported by strong performance in North America and Asia outside of China.

12 Nov
dl metro bank shop sign
FCA fines Metro Bank £16.7m for anti-money laundering failings

The Financial Conduct Authority said on Tuesday that it has fined Metro Bank £16. 7m for failing to have the right controls in place to combat money laundering.

12 Nov
dl convatec group plc ctec health care healthcare medical equipment and services medical supplies ftse 100 premium 20230328 1625
Convatec raises guidance after robust sales growth

Wound care specialist Convatec raised its guidance for the 2024 financial year on Tuesday, following robust sales growth across its divisions.

12 Nov
dl bank of georgia group plc ftse 250 bgeo financials banks logo
Bank of Georgia confident after strong third quarter, election fallout

Bank of Georgia Group reported a strong third-quarter financial performance on Tuesday, with consolidated profit for the period rising by 42. 5% year-on-year to GEL 509. 3m (£145. 29m), reflecting a return on average equity of 32. 1%.

12 Nov
dl fresnillo plc fres basic materials basic resources precious metals and mining gold mining ftse 100 premium 20230328 1811
Fresnillo partner flags problems at Silverstream mineral source

Fresnillo announced on Tuesday that Industrias Peñoles, its partner in a long-standing silver production agreement, had notified it of operational issues affecting the Sabinas mine, fully owned by Peñoles.

12 Nov
dl astrazeneca ftse 100 astra zeneca health care healthcare pharmaceuticals and biotechnology pharmaceuticals logo
AstraZeneca upgrades full-year guidance amid strong momentum

AstraZeneca upgraded its full-year revenue and earnings per share guidance on Tuesday, citing strong growth across key therapy areas and robust financial results for the first nine months of the year.